Publicaciones en las que colabora con Joaquín Portilla Sogorb (25)

2024

  1. Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe

    Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159

  2. Health-Related Quality of Life in People with Advanced HIV Disease, from 1996 to 2021: Systematic Review and Meta-analysis

    AIDS and Behavior, Vol. 28, Núm. 6, pp. 1978-1998

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

    HIV Medicine, Vol. 23, Núm. 7, pp. 705-716

  3. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Chemsex practices and health-related quality of life in spanish men with hiv who have sex with men

    Journal of Clinical Medicine, Vol. 10, Núm. 8

  3. Impact of advanced HIV disease on quality of life and mortality in the era of combined antiretroviral treatment

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-13

  4. Inflammatory Biomarkers in the Pathogenesis of Respiratory Dysfunction in People Living with HIV

    Current HIV Research, Vol. 19, Núm. 5, pp. 384-390

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  2. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

  3. How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain

    HIV Medicine, Vol. 21, Núm. 2, pp. 128-134

  4. The role of mental health conditions in the diagnosis of neurocognitive impairment in people living with HIV

    Diagnostics, Vol. 10, Núm. 8

  5. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study

    AIDS Research and Human Retroviruses, Vol. 35, Núm. 7, pp. 634-641

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

  2. Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment

    Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337

  3. Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: A qualitative approach

    BMC Women's Health, Vol. 18, Núm. 1

2017

  1. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

  2. Subclinical atherosclerosis in low Framingham risk HIV patients

    European Journal of Clinical Investigation, Vol. 47, Núm. 8, pp. 591-599